XIGEN
Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland. Dr. Christophe Bonny, CEO and co-founder, is a renowned molecular biologist with over a decade's research expertise on intracellular peptides and signalling.
XIGEN
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2002-01-01
Address:
Epalinges, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.xigenpharma.com
Total Employee:
11+
Status:
Active
Contact:
41213211081
Email Addresses:
[email protected]
Total Funding:
41 M USD
Technology used in webpage:
Google Apps For Business AJAX Libraries API Gandi.net DNS
Similar Organizations
![]()
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Current Employees Featured
![]()
Founder
![]()
![]()
Investors List

Tilocor Life Science
Tilocor Life Science investment in Series B - Xigen
![]()
Initiative Capital
Initiative Capital investment in Series A - Xigen
VI Partners
VI Partners investment in Series A - Xigen

Tilocor Life Science
Tilocor Life Science investment in Series A - Xigen
Official Site Inspections
http://www.xigenpharma.com Semrush global rank: 5.44 M Semrush visits lastest month: 1.56 K
Unable to get host informations!!!

More informations about "Xigen"
Tigen Pharma - Crunchbase Company Profile & Funding
Tigen Pharma is a biotech company that specializes in the field of cell and gene therapy ecosystems.See details»
Tigen Company Profile 2024: Valuation, Funding
Tigen General Information Description. Operator of a biotechnology company intended to provide cell therapy products to cure cancer. The company specializes in bridging the gap between academic and commercially ready โฆSee details»
Xigen Company Profile 2024: Valuation, Funding & Investors
Xigen General Information Description. Developer of innovative therapeutic peptides designed to be used against inflammation. The company's peptides have metabolic stability, and specificity โฆSee details»
ABOUT - Tigen Pharma
We are a Swiss biotech company with the vision to accelerate the access to novel therapies for patients and society. We scout for disruptive ideas, catalyse the science with state-of-the-art โฆSee details»
Xigen - Crunchbase Company Profile & Funding
Xigen SA is a private Swiss biopharmaceutical company founded in 2002 as a spin-off from the University Hospital of Lausanne (CHUV) in Switzerland.See details»
Tigen Pharma SA โ Swiss Biotech
Tigen is a Swiss clinical stage biotech company developing cell therapies to cure cancer. A disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class โฆSee details»
Tigen Pharma - Biopôle
We are a Swiss biotech company with the vision to accelerate the access to novel therapies for patients and society. We scout for disruptive ideas, catalyse the science with state-of-the-art โฆSee details»
Xigen SA - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Nov 1, 2024 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase โฆSee details»
Tigen Pharma SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tigen Pharma SA of Lausanne, VAUD. Get the latest business insights from Dun & Bradstreet.See details»
Tigen Pharma - VentureRadar
"Tigen Pharma is a science company focused on accelerating the access to novel T cell therapies for solid tumours. They collaborate with leading institutions to advance cell therapies from idea โฆSee details»
Xigen - VentureRadar
Similar Companies: Immunocore United Kingdom Publicly Traded We are a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new โฆSee details»
Xigen - Company Profile - Tracxn
Nov 26, 2024 Xigen is developing therapeutic peptides for a broad range of diseases, with a focus on inflammation. Its technology platform, Xigen ICPT enables the design and synthesis โฆSee details»
Xigen Company Profile - Office Locations, Competitors, Revenue
Xigen has 5 employees at their 1 location and $41 m in total funding,. See insights on Xigen including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
Tigen Pharma SA at the Swiss Biotech Day
Home; Sponsorship Opportunities; Registration; On Site; Attendees. Attendees 2024; Attendees 2023; Attendees 2022; Attendees 2021; Attendees 2019; Attendees 2018See details»
TEAM - Tigen Pharma
We are different and every employee is unique. A multidisciplinary team with extensive industry expertise. We go deep to come up with new ideas for scientific and technical breakthrough.See details»
Tigen Pharma SA, Lausanne | Contacts & emails - business โฆ
Website: www.tigenpharma.com. NOGA codes: A NOGA code is a standardized system for classifying businesses and economic activities. The primary use of NOGA codes is to organize โฆSee details»
SCIENCE - Tigen Pharma
We are a science company with the vision to accelerate the access to novel T cell therapies to fight liquid and solid tumours. We partner with leading institutions to take cell therapies to the โฆSee details»
Advancing Oncology Innovation: Celebrating One Year of Pfizer
4 days ago Pfizer has a longstanding commitment to advancing innovative cancer treatments to help improve outcomes for patients worldwide. One year ago, Pfizerโs acquisition of Seagen โฆSee details»
CAREER | Tigen Pharma
We are driven by future possibilities. A highly collaborative team of experts challenging existing standards and routines. Weโre committed to building a diverse team, embracing an inclusive โฆSee details»
NEWS - Tigen Pharma
We are moving fast and shaping the cell & gene landscape requires a lot of engagement amongst all stakeholders in the ecosystem. We keep you informed about the latest news on Tigen and โฆSee details»